Targeting of cell surface GRP78 likely exerts apoptotic effects via the Akt and mTOR pathways, as antibody treatment of GBM cell lines revealed decreases in phosphorylated and total Akt and mTOR. The gene discussed is AKT1; the disease is glioblastoma.